China Medical System Holdings Ltd. (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025 ...
With NIH In Chaos, Scientists Fear Trump Will Hamstring Critical Medical Research
The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...
‘Doctored’ Review: Medical Promise Betrayed
When research into an experimental drug or medical procedure is called into question, the consequences can be devastating.
The Devastating Legacy of Lies in Alzheimer’s Science
Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...